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A B S T R A C T   
Background: Exposure to high doses of ionizing radiation is known to cause cancer. Exposure during childhood is 
associated with a greater excess relative risk for leukemia and tumors of the central nervous system (CNS) than 
exposure in later life. Cancer risks associated with low-dose exposure (<100 mSv) are uncertain. We previously 
investigated the association between the incidence of childhood cancer and levels of exposure to external 
background radiation from terrestrial gamma and cosmic rays in Switzerland using data from a nationwide 
census-based cohort study. Here, we provide an update of that study using an extended follow-up period and an 
improved exposure model. 
Methods: We included all children 0–15 years of age registered in the Swiss national censuses 1990, 2000, and 
2010–2015. We identified incident cancer cases during 1990–2016 using probabilistic record linkage with the 
Swiss Childhood Cancer Registry. Exposure to terrestrial and cosmic radiation at children’s place of residence 
was estimated using geographic exposure models based on aerial spectrometric gamma-ray measurements. We 
estimated and included the contribution from 137Cs deposition after the Chernobyl accident. We created a nested 
case-control sample and fitted conditional logistic regression models adjusting for sex, year of birth, neighbor-
hood socioeconomic position, and modelled outdoor NO2 concentration. We also estimated the population 
attributable fraction for childhood cancer due to external background radiation. 
Results: We included 3,401,113 children and identified 3,137 incident cases of cancer, including 951 leukemia, 
495 lymphoma, and 701 CNS tumor cases. Median follow-up in the cohort was 6.0 years (interquartile range: 
4.3–10.1) and median cumulative exposure since birth was 8.2 mSv (range: 0–31.2). Hazard ratios per 1 mSv 
increase in cumulative dose of external background radiation were 1.04 (95% CI: 1.01–1.06) for all cancers 
combined, 1.06 (1.01–1.10) for leukemia, 1.03 (0.98–1.08) for lymphoma, and 1.06 (1.01–1.11) for CNS tumors. 
Adjustment for potential confounders had little effect on the results. Based on these results, the estimated 
population attributable fraction for leukemia and CNS tumors due to external background radiation was 32% 
(7–49%) and 34% (5–51%), respectively. 
Conclusions: Our results suggest that background ionizing radiation contributes to the risk of leukemia and CNS 
tumors in children.  
Abbreviations: ALL, Acute Lymphoblastic Leukemia; AML, Acute Myeloid Leukemia; CNS, Central Nervous System Tumor; ERR, Excess Relative Risk; GB, Great 
Britain; HR, Hazard Ratio; ICCC-3, International Classification of Childhood Cancer, Third edition; IQR, Interquartile Range; OR, Odds Ratio; PAF, Population 
Attributable Fraction; RBM, Red Bone Marrow; SCCR, Swiss Childhood Cancer Registry; SNC, Swiss National Cohort. 
* Corresponding author.University of Bern, Institute of Social and Preventive Medicine (ISPM), Mittelstrasse 43, 3012, Bern, Switzerland. 
E-mail addresses: antonella.mazzeiabba@ispm.unibe.ch (A. Mazzei-Abba), christophe.folly@ispm.unibe.ch (C.L. Folly), christian.kreis@ispm.unibe.ch (C. Kreis), 
Roland.Ammann@insel.ch (R.A. Ammann), Cecile.Adam@chuv.ch (C. Adam), eva.brack@insel.ch (E. Brack), matthias.egger@ispm.unibe.ch (M. Egger), claudia. 
kuehni@ispm.unibe.ch (C.E. Kuehni), ben.spycher@ispm.unibe.ch (B.D. Spycher).  
Contents lists available at ScienceDirect 
Journal of Environmental Radioactivity 
journal homepage: www.elsevier.com/locate/jenvrad 
https://doi.org/10.1016/j.jenvrad.2021.106734 
Received 29 March 2021; Received in revised form 27 August 2021; Accepted 28 August 2021   
Journal of Environmental Radioactivity 238–239 (2021) 106734
2
1. Introduction 
Ionizing radiation increases cancer risk in medium to high doses 
(UNSCEAR, 2006). For some types of cancer, relative increases in risk 
are higher following exposure during childhood (0–16 years of age) 
compared to exposure in adulthood (UNSCEAR, 2013). These include 
leukemia and tumors of the central nervous system (CNS), the most 
common childhood malignancies (Steliarova-Foucher et al., 2017). 
Leukemia is particularly sensitive to induction by radiation exposure, 
and disease onset may follow after a short latency of about two years 
(UNSCEAR, 2006). Low-dose exposure in the general population, for 
example, from background radiation or diagnostic radiology, may 
contribute to the risk of childhood cancer, particularly leukemia 
(Hauptmann et al., 2020; Laurent et al., 2013; Little et al., 2018; 
Wakeford et al., 2009). 
Direct epidemiological evidence of the risk associated with low doses 
(<100 mSv) is difficult to obtain due to sample size requirements and 
the challenge of reliable dosimetry for large samples. Scientific com-
mittees generally assume that the risks associated with low doses can be 
extrapolated from linear/linear quadratic non-threshold models (LNT) 
developed from data of populations exposed to moderate and high 
doses, mainly from the Japanese atomic bomb survivors cohort 
(UNSCEAR, 2006). This assumption has been the subject of debate 
(Boice, 2017; Little et al., 2009b). However, the LNT model seems to be 
consistent with a majority of recent high-quality epidemiologic studies 
(Shore et al., 2018). Recent reviews suggest that low-dose exposure in-
creases the risks for leukemia and CNS tumors (Berrington de Gonzalez 
et al., 2016; Hauptmann et al., 2020; Little et al., 2018). A pooled 
analysis of nine cohort studies including medically exposed populations 
and atomic bomb survivors found evidence of a positive dose-response 
relationship between the risk of acute leukemia and exposure at age 
<20 years to cumulative doses of <100 mSv (Little et al., 2018). 
The excess cancer risks associated with low-dose ionizing radiation 
are expected to be small, and large sample sizes are needed to detect 
them. Achieving the required large sample sizes in studies based on 
interviews and measurements is difficult, and such studies have been 
underpowered (Kendall et al., 2021). 
Over the last decade, several nationwide registry-based studies have 
investigated associations of exposure to natural background radiation 
and childhood cancer, mainly leukemia, with conflicting results (Berli-
vet et al., 2019; Demoury et al., 2016; Kendall et al., 2013; Nikkila et al., 
2016; Spix et al., 2017; Spycher et al., 2015b). These studies relied on 
comprehensive cancer registries and other national routine datasets and 
required no active participation by study members, thereby minimizing 
the risk of selection bias. Nevertheless, a recent review of these studies 
highlighted the need for improved exposure models and increased 
sample sizes (Mazzei-Abba et al., 2020). A recent meta-analysis that 
included some of these studies and studies on medical exposure also 
reported a positive association between childhood leukemia and doses 
of <100 mSv (Hauptmann et al., 2020). 
We aimed to investigate the association between external exposure 
to background gamma radiation and incidence of childhood cancers, 
including leukemias, lymphomas, and CNS tumors, in a nationwide 
cohort study in Switzerland. Given the diverse geology and topography 
of Switzerland, exposure to background radiation varies considerably by 
location. This study updates a previously published analysis of the same 
cohort, which reported increased risks of childhood leukemias and CNS 
tumors related to cumulative doses from external background radiation 
(Spycher et al., 2015b). The present study is based on a longer study 
period, a larger sample size, and an improved exposure model based on 
outdoor measurements. In the present study, we also estimate the pop-
ulation attributable fraction (PAF) for leukemias and CNS tumors due to 
external background radiation. 
2. Methods 
2.1. Population 
Our study population consisted of children aged 0–15 years regis-
tered in the Swiss national censuses in 1990 and 2000 (decennial cen-
suses) and 2010–2015 (annual population registry-based censuses). 
Data on this population were obtained from the Swiss National Cohort 
(SNC) study, a research platform linking the national censuses with 
national datasets on births, mortality, and migration (Spoerri et al., 
2010). Records were linked probabilistically between the censuses of 
1990, 2000, and 2011 and deterministically for the years 2010–2015. 
We obtained precise geocodes of children’s places of residence which 
were available for census time points. 
2.2. Outcomes 
We identified incident cases of childhood cancer diagnosed during 
the study period 1990–2016 in the cohort through probabilistic record 
linkage of the SNC with the Swiss Childhood Cancer Registry (SCCR). 
The linkage was based on the variables sex, date of birth, maternal and 
paternal dates of birth, geocodes of residential address and municipality 
of residence at the census, and nationality. Incident cases among chil-
dren who migrated into Switzerland after 2011 had not yet been linked 
at the time of analysis and were thus excluded from the cohort. The 
SCCR is estimated to include about 95% of all cancer diagnoses in 
Switzerland in the age group 0–15 years during the study period 
(Schindler et al., 2015). 
We investigated the following outcomes, grouped according to the 
International Classification of Childhood Cancers (ICCC-3) (Steliar-
ova-Foucher et al., 2005): any cancer type (ICCC-3 main groups I-XII), 
leukemias (ICCC-3 main group I), acute lymphoblastic leukemias (ALL) 
(ICCC-3 subgroup Ia), acute myeloid leukemias (AML) (Ib), lymphomas 
(II), CNS tumors (III), and other malignant tumors (IV–XII). Cases of 
Langerhans cell histiocytosis registered in the SCCR were included in the 
outcome group “other malignant tumors”. For comparison with a pre-
vious study in France that examined CNS tumor subtypes and back-
ground radiation (Berlivet et al., 2019), we also examined 
ependymomas and plexus choroid tumors (IIIa), intracranial and intra-
spinal embryonal tumors (IIIc), gliomas (IIIb, IIId, IIIe4), and pilocytic 
astrocytomas separately from other gliomas. 
2.3. Exposure assessment 
We assessed exposure to external background radiation as the sum of 
the estimated exposures to natural terrestrial gamma radiation, cosmic 
radiation, and the gamma radiation originating from 137Cs deposition 
after the Chernobyl accident. Exposure to terrestrial radiation was 
assessed as the outdoor ambient dose rate at children’s place of resi-
dence at census based on a geographic exposure model developed by our 
team. The model has a resolution of 100 × 100m and is based on 
airborne gamma spectrometry measurements provided by the Swiss 
Federal Nuclear Safety Inspectorate (ENSI). The measurements were 
taken from a helicopter flying at roughly 90m altitude. The flight paths 
covered areas around nuclear facilities and areas of high population 
density. They included long-distance traversals across the country as 
well as targeted flights to sites of known local anomalies of natural 
sources. We fitted a Bayesian spatial model including over 40′000 
measurements with the following predictor variables: maps of tectonics 
(19 categories) and lithology (5 categories) (geological maps provided 
by the Federal Office of Topography), land cover (6 categories, Federal 
Statistical Office) and cumulative daily rainfall following the Chernobyl 
accident to capture the effect of 137Cs deposition (MeteoSwiss). The 
exposure model is described in more detail elsewhere (Folly et al., 
2021). 
The airborne measurements used to model terrestrial radiation were 
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mostly conducted after 2000, capturing 137Cs-levels during the later part 
of our study period. In order to adjust for the higher levels of 137Cs at the 
beginning of the study period, we first subtracted the contribution of 
137Cs from the developed model for terrestrial radiation and added a 
time-varying cesium component. The latter was modelled using as 
starting point a previously developed map of Switzerland showing 
concentrations of 137Cs in 1989 (Rybach et al., 1996) and applying an 
exponential decay function over time (from 1986 to 2015). The decay 
rate was estimated using measurements of 137Cs levels taken during 
1989–2018 at 26 fixed locations across the country (see Appendix A for 
more details). Finally, we estimated exposure to cosmic rays as a 
deterministic function of altitude at the residential address: Dose rate 
[nSv/h] = 37.0 exp (0.38 altitude [km]) (Bundesamt fuer Gesund-
heitswesen, 1994). 
2.4. Potential confounders and covariates 
We adjusted our models for potential confounding by the degree of 
urbanization at the municipal level (urban, peri-urban, rural), socio-
economic status (Swiss neighborhood index of socioeconomic position 
assessed in 2000 based on median rent, education and occupation of 
household heads, and household crowding, in quintiles) (Adam et al., 
2015; Panczak et al., 2012), and traffic-related air pollution (modelled 
annual mean ambient air concentration of NO2, time-varying covariate). 
We also adjusted for the presence of a cantonal cancer registry in certain 
regions during the observation period (annually time-varying). The 
SCCR has nationwide coverage, but registration is expected to be slightly 
more complete in cantons with a general cantonal registry, as data from 
these registries were used to register any cases missed out by the SCCR. 
2.5. Statistical analyses 
Children entered the cohort on the date of the first census, in which a 
child was recorded with complete address information, and were 
considered at risk until diagnosis, death, emigration, 16th birthday, loss 
to follow-up, or administrative censoring at the end of follow-up 
(December 31st, 2016), whichever occurred first. For children who 
relocated between censuses, exposure was adjusted to the precise date of 
relocation, if known, or to the mid-point between the two nearest time 
points with a known location. We thus reconstructed address histories to 
the full extent possible using all available residential address 
information. 
As exposure variables we considered i) cumulative dose in mSv since 
birth and ii) ambient dose rate in nSv/h at entry into the cohort. We 
calculated cumulative exposure by integrating the total dose rate from 
birth to diagnosis. We also considered cumulative exposure lagged by 24 
months and 5 years to account for the lag time between exposure and 
potential development of cancer (UNSCEAR, 2006). We included 
exposure variables both as continuous (entered as a linear term) and 
categorical variables in separate models. To define categories, we used 
regularly spaced intervals (4 mSv for cumulative exposure and 25 nSv/h 
for dose rate) around the median and merged neighboring categories 
until no interval contained less than 1% of the total population. 
To reduce the computational burden and facilitate the analysis of a 
time-varying exposure (cumulative dose), we created a nested case- 
control dataset. We randomly sampled 100 controls per case without 
replacement from the population at risk at the time of a case’s diagnosis 
(risk set sampling), additionally matching on year of birth. We fitted 
conditional logistic regression models conditioning on the matched 
case-control sets. This procedure is asymptotically (with increasing 
sample size) equivalent to Cox proportional hazards regression using the 
full cohort with age as the underlying time scale (Goldstein and Lan-
gholz, 1992). Given this equivalence, we refer to the odds ratios esti-
mated from these conditional logistic regression models as hazard ratios. 
All models were adjusted for sex (minimally adjusted models), while, in 
separate models, we adjusted for the other potential confounders (fully 
adjusted models). 
To investigate the potential impact of exposure misclassification, we 
conducted a sensitivity analysis by restricting the cohort to children with 
a stable place of residence before entry into the cohort or with fully 
known address histories. 
For leukemia and CNS tumors, we also estimated the population 
attributable fraction (PAF) and the annual attributable number of 
childhood cancer cases due to cumulative exposure to external back-
ground radiation. These calculations were based on the estimated dose 
coefficients from models including a linear exposure term and on age- 
specific cancer incidence rates and exposure distributions during the 
period 2000–2015 (see Appendix B for details). 
3. Results 
The SNC included a total of 3,493,769 children 0–15 years of age 
who contributed 24,6 million person-years at risk during the period of 
1990–2016. After excluding children who migrated into Switzerland 
after 2011 (see methods), the final analysis included 3,401,113 children 
and 24.4 million person-years at risk (Table 1). Median age of children at 
entry into the cohort was 5.4 years (interquartile range (IQR): 1.9–9.0) 
and median total follow-up time was 6.0 years (IQR: 4.3–10.1). In the 
SCCR, we identified 5,627 childhood cancer cases diagnosed during the 
study period. Of these, 3,137 could be linked to the cohort and were 
available for analysis (Fig. 1) including 951 cases of leukemia, 495 cases 
of lymphoma, 701 cases of CNS tumors, and 990 cases of other malig-
nant tumors. 
Table 1 
Characteristics of the study population at the time of entry into the cohorta.   
N (%) Person-years Cancer cases 
Total 3,401,113 (100) 24,432,588 3,137 
Sex 
Male 1,745,303 (51.3) 12,525,252 1,743 
Female 1,655,810 (48.7) 11,907,336 1,394 
Year of birth 
1974–1979 379,591 (11.2) 948,126 71 
1980–1989 837,680 (24.6) 7,791,602 832 
1990–1999 880,751 (25.9) 8,797,102 1,176 
2000–2009 806,430 (23.7) 5,230,766 771 
2010–2015 496,661 (14.6) 1,664,992 287 
Year of entry into cohort 
1990 1,238,297 (36.4) 9,724,639 1,067 
2000 865,470 (25.4) 8,662,554 1,140 
2010 848,353 (24.9) 4,732,456 711 
2011–2015 448,993 (13.2) 1,312,939 219 
Degree of urbanization    
Urban 861,574 (25.3) 5,772,791 783 
Peri-urban 1,558,566 (45.8) 11,252,160 1,447 
Rural 980,973 (28.8) 7,407,638 907 
Swiss-SEP index 
1st quintile (low SEP) 901,274 (26.5) 6,305,009 828 
2nd quintile 701,515 (20.6) 5,052,884 613 
3rd quintile 648,841 (19.1) 4,721,496 626 
4th quintile 613,232 (18.0) 4,495,890 582 
5th quintile (high SEP) 536,251 (15.8) 3,857,310 488 
NO2 
1st quartile 804,267 (23.6) 6,569,155 738 
2nd quartile 802,972 (23.6) 6,237,041 731 
3rd quartile 851,467 (25.0) 6,114,959 772 
4th quartile 942,142 (27.7) 5,509,605 895 
Missing 265   
External background radiation (nSv/h) at entry in the cohort 
0 - <100 2,154,243 (63.3) 15,131,249 1,948 
100 - <125 1,031,379 (30.3) 7,731,894 961 
125 - <150 99,394 (2.9) 676,446 93 
150 - 264 1,16,097 (3.4) 892,998 135 
Abbreviations 
SEP: Swiss neighborhood index of socioeconomic position. 
a Time of entry into cohort corresponds to the first census in which the child 
was recorded with full address information. 
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Children’s median exposure to external background radiation at 
entry into the cohort was 96.4 nSv/h (range: 62.5–263.2) (Fig. 2 and 
Table C1 in appendix). The terrestrial gamma component contributed 
most to children’s total dose and also showed the highest variability 
between individuals (median: 47.5 nSv/h, range: 16.3–168.3). In the 
nested case-control sample, median cumulative exposure since birth 
among controls, assessed at the age of diagnosis of the matched case, 
was 8.2 mSv (range: 0–31.2) (Fig. 2 and Table C1 in the appendix). 
In conditional logistic regression analyses, we found evidence of a 
positive association between cumulative dose since birth, included as a 
linear term, and the risk of any cancer (fully adjusted HR per mSv: 1.04; 
95% CI: 1.01–1.06), leukemia (1.06; 1.01–1.10), CNS tumors (1.06; 
1.01–1.11), AML (1.09; 0.99–1.19), and ALL (1.04; 0.98–1.10) (Table 2 
upper panel). We observed similar positive associations for all subtypes 
of CNS tumors. Our results were similar when considering a latent 
period of 24 months (Table 2, lower panel). When considering a 5-year 
latency period, results were similar, however, sample size was consid-
erably reduced and confidence intervals were larger (Table C2). For CNS 
tumors confidence intervals where compatible with no association, 
while associations for leukaemia were somewhat stronger. When 
including cumulative exposure as a categorical exposure variable, risks 
were consistently higher for the highest exposure category (>12 mSv) 
compared to the baseline category (<4 mSv) for all main groups of 
childhood cancer (Fig. 3 and Table C3 in the appendix), but confidence 
intervals were large. 
Analyses of cancer risks by ambient dose rate at children’s homes at 
entry into the cohort showed a similar pattern. The adjusted HR for a 
difference of 100 nSv/h in ambient dose rate for all cancers combined 
was 1.35 (1.11–1.65) and 1.33 (0.93–1.90) for leukemia. The strongest 
associations were again seen for AML (1.92; 0.83–4.40) and CNS tumors 
(1.49; 0.98–2.25) (Table 3). When using categories of exposure, the risk 
was higher for children exposed to doses of >150 nSv/h compared to 
those exposed to <100 nSv/h for all the main cancer subtypes (Table C4 
in the appendix), but confidence intervals were again wide. 
The sensitivity analysis, including only children with stable resi-
dence or with fully known address history, included 1,764,131 children 
(51.8% of the entire cohort) and 1,854 cancer cases. In this subcohort, 
associations with cumulative dose were higher for leukemia (1.08; 
1.02–1.15) and ALL (1.08; 1.00–1.15) but lower for CNS tumors (1.02; 
0.96–1.09) compared to the main analyses (Table C5 and C6 in the 
appendix). Results were similar for minimally adjusted and fully 
adjusted models (Table C3 and C4). 
The PAF was estimated at 32.2% (7.0–49.3) for leukemia and 33.6% 
(5.5–51.0) for CNS tumors (Table 4). 
4. Discussion 
This study found renewed evidence that exposure to higher levels of 
external background ionizing radiation is associated with an increased 
risk of childhood cancer. In the analysis of cumulative dose received 
since birth, the risks were higher for leukemia and CNS tumors 
compared to other outcomes. We also found evidence of an increased 
risk of childhood cancer with ambient dose rate. Our estimation of the 
PAF suggests that a considerable fraction of childhood leukemia and 
CNS tumor cases might be caused by exposure to external background 
radiation. Adjustments for potential confounding had little effect on the 
results of the analyses. 
Our results are consistent with the previous study in Switzerland, 
which reported an HR per mSv of 1.04 (1.00–1.08) for leukemia and 
1.04 (1.00–1.08) for CNS tumors (Spycher et al., 2015b) (Table C7). The 
data sources of these two studies are identical and overlap for the period 
1990–2008. In the present study, however, we extended the follow-up 
until 2016, and thus almost doubled the number of included leukemia 
and CNS tumor cases, adding to the statistical power of the study. Also, 
the present analysis is based on an improved exposure model. Compared 
to the previous study (Rybach et al., 1996, 2002), the present model was 
based on a broader and denser coverage of populated areas, including 
the major cities but also rural and mountainous areas (Folly et al., 2021). 
The broader coverage of measurements and inclusion of a time-varying 
cesium component have likely reduced exposure misclassification, 
particularly in the canton of Ticino, where the contribution from 137Cs to 
exposure in the general population was substantial. 
The extrapolations from standard risk models developed using data 
from atomic bomb survivors suggest that an excess relative risk (ERR) of 
around 5% per mSv for leukemia might be applicable to a population 
Fig. 1. Flow chart of childhood cancer cases included in analyses. 
Abbreviations 
SCCR: Swiss Childhood Cancer Registry 
SNC: Swiss National Cohort 
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exposed to low doses in early life (Wakeford, 2013). In the present study, 
we found a relative risk of 1.06 (95% CI: 1.01–1.10) per mSv corre-
sponding to an ERR of 6% per mSv, which is in broad agreement with 
these extrapolations, although still fraught with large uncertainties. 
Based on the extrapolations from standard risk models, risk assessment 
studies estimated that the proportion of cases of childhood leukemia due 
to exposure to natural sources of radiation (including external radiation 
and inhaled radon) may be as high as 20% in France and Great Britain 
(GB) (Laurent et al., 2013; Little et al., 2009a). Based on direct esti-
mation of risks associated with background radiation in Switzerland, we 
estimate this proportion to be 32% (7–49%) from external radiation 
alone. However, the uncertainty in all studies is large and caution is 
required in applying these risk models derived from populations 
exposed acutely to medium and high doses to protracted exposure to 
low-dose rates (Little et al., 2009b). 
Studies of areas of high natural background radiation have been 
conducted in Kerala, India and Yangjiang, China and found little or no 
effect after low dose-rate exposures. However, these studies have several 
limitations that hinder the interpretation of results: substantial un-
certainties in dosimetry, the weaknesses in cancer ascertainment in 
Yangjiang, low statistical power, and potential confounding by varia-
tions in lifestyles and risk factors in the different geographic regions 
associated with different levels of radiation (Shore et al., 2018). 
Importantly, these studies did not include children. 
Over the last decade, other European countries have conducted 
similar studies to the present one with conflicting results. A detailed 
comparison of their methodologies and results can be found elsewhere 
(Mazzei-Abba et al., 2020). Our results for leukemia are consistent with 
a record-based case–control study conducted in GB by Kendall and 
colleagues (Kendall et al., 2013). Compared to our study, their point 
estimates per mSv cumulative dose, measured as equivalent dose to the 
red bone marrow (RBM), were larger for leukemia (OR: 1.12, 95% CI: 
1.03–1.22) and smaller for CNS tumors (1.02, 95% CI: 0.96–1.09). In 
contrast, a large register-based study from France found no evidence of 
increased risks for childhood leukemia related to terrestrial gamma ra-
diation, reporting confidence intervals for the RR per mSv of cumulative 
dose to the RBM centered narrowly around 1 (RR: 1.00, 95% CI: 
0.99–1.01) (Demoury et al., 2016). A nationwide case-control study in 
Finland found no evidence of an association with childhood leukemia 
(RR: 1.01, 95% CI: 0.97–1.05 for 1 mSv unit increase in cumulative dose 
to RBM from terrestrial gamma); however, in subgroup analyses, leu-
kemia diagnosed at ages 2–6 years was positively associated with cu-
mulative dose (1.27, 95% CI: 1.01–1.60) (Nikkila et al., 2016). A recent 
ecological study from Germany including a large number of cases found 
no evidence of an association between childhood leukemia rates and 
mean gamma-ray exposure at the municipality level (Spix et al., 2017), 
but confidence intervals were compatible with the findings of other 
Fig. 2. Ambient dose rate (left) and cumulative doses since birth (right) from external background radiation. 
Values for ambient dose rate are at the time of entry into the cohort. 
Table 2 
Hazard ratio (HR) for childhood cancer per mSv increase in cumulative equiv-
alent dose from external background radiation.    
Minimally adjusted a Fully adjusted b  
Cases HRc (95% CI) HRc (95% CI) 
0 months latency period 
All cancers 3,137 1.03 (1.01, 1.06) 1.04 (1.01, 1.06) 
Leukemia 951 1.04 (1.00, 1.09) 1.06 (1.01, 1.10) 
ALL 754 1.03 (0.98, 1.08) 1.04 (0.98, 1.10) 
AML 133 1.07 (0.98, 1.17) 1.09 (0.99, 1.19) 
Lymphoma 495 1.02 (0.97, 1.07) 1.03 (0.98, 1.08) 
CNS tumor 701 1.06 (1.01, 1.11) 1.06 (1.01, 1.11) 
Ependymomas 52 1.11 (0.94, 1.30) 1.09 (0.92, 1.30) 
Embryonal tumor 129 1.09 (0.99, 1.21) 1.09 (0.98, 1.21) 
Gliomas 425 1.05 (0.99, 1.11) 1.05 (0.98, 1.11) 
Pilocytic astrocytomas 178 1.03 (0.93, 1.13) 1.01 (0.91, 1.13) 
Other gliomas 247 1.06 (0.98, 1.14) 1.06 (0.98, 1.15) 
Other 990 1.02 (0.98, 1.06) 1.01 (0.97, 1.06) 
24 months latency period 
All cancers 2,248 1.04 (1.01, 1.07) 1.04 (1.01, 1.07) 
Leukemia 615 1.05 (0.99, 1.11) 1.06 (1.00, 1.13) 
ALL 479 1.03 (0.96, 1.10) 1.04 (0.97, 1.12) 
AML 94 1.10 (0.99, 1.22) 1.11 (0.99, 1.23) 
Lymphoma 415 1.01 (0.96, 1.08) 1.03 (0.97, 1.09) 
CNS tumor 521 1.08 (1.02, 1.14) 1.06 (1.00, 1.13) 
Ependymomas 28 1.13 (0.91, 1.41) 1.09 (0.86, 1.39) 
Embryonal tumor 95 1.13 (1.00, 1.29) 1.11 (0.97, 1.27) 
Gliomas 314 1.05 (0.98, 1.14) 1.04 (0.96, 1.13) 
Pilocytic astrocytomas 130 1.04 (0.93, 1.17) 1.00 (0.88, 1.15) 
Other gliomas 184 1.06 (0.97, 1.17) 1.07 (0.96, 1.18) 
Other 697 1.02 (0.98, 1.07) 1.00 (0.95, 1.06) 
Abreviations: 
ALL: Acute Lymphoid Leukemia 
AML: Acute Myeloid Leukemia 
CNS: Central Nervous System. 
a Models adjusted only by sex. 
b Models adjusted by sex, degree of urbanization, availability of cantonal 
cancer registry, quintiles of socioeconomic status, and NO2. In the fully adjusted 
analysis, one case of CNS tumors (glioma) was not included as its value for NO2 
was not available. 
c HRs are obtained as the odds ratios from conditional logistic regression 
models fitted to nested case-control datasets matched on age (risk set sampling) 
and year of birth. 
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studies including this one. 
The evidence base on childhood CNS tumors and background radi-
ation is smaller than for leukemia. The most recent study, an ecological 
study from France, reported a positive association only for the subgroup 
of pilocytic astrocytoma with an incidence rate ratio of 1.15 (95% CI: 
0.99–1.33) per 5 mSv difference in cumulative gamma dose (Berlivet 
et al., 2019). For comparison purposes, we explored the association with 
pilocytic astrocytoma in our cohort, finding little evidence of an asso-
ciation (1.05; 0.62–1.84 per 5 mSv). In Germany, an ecological study 
reported a relative risk of 1.35 (95% CI: 1.17–1.57) for childhood CNS 
tumors, comparing a gamma dose rate of 1.5 mSv/y to 0.5 mSv/y (Spix 
et al., 2017). Both these studies are in agreement with our results. 
However, the elevated risks found for CNS tumors were considerably 
reduced in our study when restricting the analysis to the cohort of 
children with known residential history for whom the risk of exposure 
misclassification was smaller (Table C6). 
We found little evidence of an association for lymphoma, which is 
consitent with the lack of evidence from most studies that investigated 
the risks of lymphoma associated with exposure to ionizing radiation 
(Little et al., 2021; UNSCEAR, 2006). A recent pooled analysis of mul-
tiple cohorts found no evidence of an increased risks of lymphoma in 
relation to bone marrow dose, but did find indications of an excess risk 
for non-Hodgkin lymphoma when using lymphatic tissue dose (Little 
Fig. 3. Hazard ratios (HR) for cancer by categories of cumulative dose from 
external background radiation. 
Hazard ratios for A) All cancers combined; B) Leukemia; C) Lymphoma; D) CNS 
tumors; and E) Other cancers. The dashed grey line indicates a hazard ratio of 1. 
The point estimates show the fitted model with a categorical exposure term and 
are placed at median cumulative dose within categories. The dose boundaries 
used for categories are 0, 4, 8, 12, and 30 mSv with risk in the 0–4 mSv group 
defining the baseline risk. The dashed orange line shows the fitted model with a 
linear exposure term. The line is vertically placed so as to pass through 1 at the 
median dose of the baseline category. This choice is, however, arbitrary as 
conditional logistic regression models do not include an intercept. 
Table 3 
Hazard rations (HR) for childhood cancer per 100nSv/h increase in ambient 
dose rate of external background radiation at entry into cohort.    
Minimally adjusteda Fully adjustedb  
Cases HRc per 100nSv/h 
(95% CI) 
HRc per 100nSv/h 
(95% CI) 
0 months latency period 
All cancers 3,137 1.32 (1.10, 1.59) 1.35 (1.11, 1.65) 
Leukemia 951 1.20 (0.85, 1.71) 1.33 (0.93, 1.90) 
ALL 754 1.08 (0.71, 1.62) 1.17 (0.77, 1.79) 
AML 133 1.71 (0.75, 3.92) 1.92 (0.83, 4.40) 
Lymphoma 495 1.17 (0.73, 1.87) 1.27 (0.78, 2.05) 
CNS tumor 701 1.52 (1.03, 2.24) 1.49 (0.98, 2.25) 
Ependymomas 52 2.49 (0.69, 8.94) 2.27 (0.57, 9.09) 
Embryonal tumor 129 2.02 (0.89, 4.58) 2.03 (0.87, 4.70) 
Gliomas 425 1.34 (0.79, 2.25) 1.29 (0.73, 2.28) 
Pilocytic 
astrocytomas 
178 0.98 (0.40, 2.39) 0.84 (0.31, 2.25) 
Other gliomas 247 1.60 (0.84, 3.04) 1.61 (0.81, 3.21) 
Other 990 1.38 (1.00, 1.92) 1.33 (0.94, 1.87)     
24 months latency period 
All cancers 2,248 1.36 (1.10, 1.70) 1.32 (1.05, 1.66) 
Leukemia 615 1.30 (0.85, 2.01) 1.44 (0.93, 2.25) 
ALL 479 1.09 (0.65, 1.83) 1.25 (0.73, 2.14) 
AML 94 2.02 (0.80, 5.08) 2.12 (0.85, 5.33) 
Lymphoma 415 1.11 (0.65, 1.88) 1.24 (0.72, 2.13) 
CNS tumor 521 1.83 (1.19, 2.79) 1.62 (1.02, 2.57) 
Ependymomas 28 4.70 (1.09, 20.24) 3.95 (0.8, 19.58) 
Embryonal tumor 95 2.63 (1.09, 6.36) 2.35 (0.92, 6.02) 
Gliomas 314 1.48 (0.83, 2.65) 1.28 (0.67, 2.46) 
Pilocytic 
astrocytomas 
130 1.31 (0.50, 3.42) 0.95 (0.32, 2.83) 
Other gliomas 184 1.60 (0.77, 3.32) 1.57 (0.70, 3.51) 
Other 697 1.27 (0.86, 1.88) 1.09 (0.72, 1.66) 
Abreviations: 
ALL: Acute Lymphoid Leukemia 
AML: Acute Myeloid Leukemia 
CNS: Central Nervous System. 
a Models adjusted only by sex. 
b Models adjusted by sex, degree of urbanization, availability of cantonal 
cancer registry, quintiles of socioeconomic status, and NO2. In the fully adjusted 
analysis, one case of CNS tumors (glioma) was not included as its value for NO2 
was not available. 
c HRs are obtained as the odds ratios from conditional logistic regression 
models fitted to nested case-control datasets matched on age (risk set sampling) 
and year of birth. 
Table 4 
Estimated population attributable fraction (PAF) and annual attributable cases 
of childhood cancer due to cumulative exposure to external background radia-
tion in Switzerland.   
PAFa in % Annual attributable casesa 
(95% CIb) (95% CIb) 
Leukemia 32.2 (7.0, 49.3) 21 (5, 32) 
CNS tumors 33.6 (5.5, 51.0) 17 (3, 26) 
Abreviations: 
CNS: Central Nervous System. 
a Values are based on the exposure distribution and cancer incidence during 
the period 2000–2015 and on the dose coefficient from fitted models including a 
linear exposure term adjusted by sex, degree of urbanization, availability of 
cantonal cancer registry, quintiles of socioeconomic status, and NO2. 
b 95% CIs were obtained by repeating the calculations using the lower and 
upper confidence limits of dose coefficient instead of the point estimate. 
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et al., 2021). 
The major strengths of our study are the nationwide cohort design, 
which maximizes sample size while minimizing the risk of selection bias, 
and the availability of exact geocodes of children’s residential addresses 
at census time. A large amount of available airborne gamma-ray mea-
surements provided a dense coverage of many heavily populated areas. 
The exposure model showed good performance in an internal validation 
with a coefficient of determination (R2) of 0.75 in random cross- 
validation, and 0.40 in spatial cross-validation (Folly et al., 2021). 
Furthermore, we specifically modelled the depletion in the surface soil 
and the decay of 137Cs contamination from the Chernobyl accident. 
Our study did not include other important sources of radiation 
exposure in the general population such as domestic radon, diagnostic 
radiology, and ingested radionuclides, which may have confounded the 
associations estimated for external background radiation. However, this 
is unlikely for radon, as its decay products are mainly deposited in the 
respiratory tract and deliver the largest doses there. A previous study 
using overlapping data with the present study found no evidence of an 
association between estimated concentrations of domestic radon and 
childhood cancer risks (Hauri et al., 2013). A correlation between doses 
from ingested radionuclides and terrestrial gamma radiation is plausible 
as some proportion of drinking water and consumed agricultural food 
products come from local sources. A further limitation of this study is 
that exposure assessment was based only on outdoor measurements. 
Indoor exposure, where children spend most of their time, may differ 
considerably from outdoor exposure due to shielding effects and radia-
tion stemming from building materials (UNSCEAR, 2008). Unfortu-
nately, there was no sufficiently large dataset with indoor measurements 
of gamma radiation available. Also, modelling indoor exposure would 
have been further complicated by the lack of routine data on building 
materials. Another cause for potential exposure misclassification was 
our incomplete knowledge of residential histories. However, a recent 
study summarizing data from different European countries found that 
analyses based on a single address, which may introduce some mea-
surement error, should still capture a large proportion of variability 
between individuals in exposure to background radiation (Nikkila et al., 
2018). 
Our study may have been affected by differential (by exposure) 
misclassification of the outcomes. Schindler et al. (2015) investigated 
completeness of the SCCR and found that children with brain tumors had 
been more likely to be missed in the registry than leukemias. The same 
study also found evidence of regional differences in the completeness of 
registration. We attempted to adjust for this by including a time-varying 
covariate indicating the presence of a general cancer registry in the 
canton of residence in our models. Lastly, not all eligible incident cases 
could be linked with the SNC, and some of the linked cases may have 
been falsely matched. This was another potential source of differential 
outcome misclassification that we could not account for. 
The increased risk in childhood cancer was mainly driven by the risk 
observed for leukemia and CNS tumors. We cannot rule out bias from 
unmeasured confounding or measurement error. Indeed, restricting the 
analysis to children with fully known residential histories increased the 
strength of the association for leukemia but reduced it for CNS tumors. 
However, this shift in the observed associations could be due to other 
causes than the lower risk of exposure misclassification. Children in the 
restricted cohort were on average younger and followed-up for shorter 
periods. This could have differentially affected the analyses for leukemia 
and CNS tumors as cases of the former show a characteristic peak be-
tween ages 2–5 years (SCCR, 2019) whereas the latter are more evenly 
distributed across ages. 
Regarding the risk of confounding, neither leukemia nor CNS tumors 
have known environmental risk factors apart from ionizing radiation. 
We found no indication of an association between exposure to domestic 
radon and childhood cancers in Switzerland in a previous study (Hauri 
et al., 2013) and thus did not include radon in the present analysis. We 
did consider exposure to traffic-related air pollution as a potential 
confounder for which there is support for an association with childhood 
leukemia from a recent systematic review and meta-analysis (Filippini 
et al., 2018) and a previous study in Switzerland (Spycher et al., 2015a, 
b). The included potential confounders had little effect on the results. 
However, we cannot exclude the possibility of residual confounding by 
other potential risk factors including other sources of radiation exposure 
such as diagnostic radiology or ingested radionuclides, for which we had 
no data available. 
Assuming that the estimated dose-response relationships reflect a 
causal effect, our results suggest that external exposure to background 
radiation due to terrestrial gamma and cosmic radiation accounts for a 
considerable proportion of leukemia and CNS malignancies occurring in 
children. 
5. Conclusion 
Overall, these results provide further support that external natural 
background radiation may contribute to observed cancer rates in chil-
dren, particularly of leukemia and CNS tumors. 
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